share_log

Novo Integrated Sciences | 8-K: Current report

Novo Integrated Sciences | 8-K: Current report

Novo Integrated Sciences | 8-K:重大事件
美股sec公告 ·  06/05 15:02
Moomoo AI 已提取核心訊息
On June 5, 2024, Novo Integrated Sciences, Inc. announced that its subsidiary, Acenzia Inc., has been chosen by Protein Industries Canada to participate in a project aimed at introducing new protein products with enhanced nutritional profiles to the global market. The project, with a total investment of approximately $5.4 million, will focus on the development, reformulation, and commercialization of three consumer-ready protein products. Acenzia will contribute around $600,000, while Protein Industries Canada and two other partner companies will invest $2.3 million and $2.5 million, respectively. The initiative will span three phases and aims to offer plant-based protein alternatives that are comparable to whey protein isolate in terms of quality, sensory experience, and muscle health benefits. The products are intended for various consumer segments, including...Show More
On June 5, 2024, Novo Integrated Sciences, Inc. announced that its subsidiary, Acenzia Inc., has been chosen by Protein Industries Canada to participate in a project aimed at introducing new protein products with enhanced nutritional profiles to the global market. The project, with a total investment of approximately $5.4 million, will focus on the development, reformulation, and commercialization of three consumer-ready protein products. Acenzia will contribute around $600,000, while Protein Industries Canada and two other partner companies will invest $2.3 million and $2.5 million, respectively. The initiative will span three phases and aims to offer plant-based protein alternatives that are comparable to whey protein isolate in terms of quality, sensory experience, and muscle health benefits. The products are intended for various consumer segments, including medical nutrition, active living, and high-performance sports. Acenzia's involvement leverages its expertise in contract manufacturing, product formulation, R&D, and sustainable packaging to create ecologically friendly, evidence-based plant protein products. Novo Integrated Sciences, Inc., the parent company, is known for its multidisciplinary healthcare ecosystem and product innovation, focusing on a holistic approach to health and wellness.
2024年6月5日,Novo Integrated Sciences, Inc.宣佈其子公司Acenzia Inc.被Protein Industries Canada選為參與項目的合夥人,旨在將具有增強營養價值的新蛋白產品引入全球市場。該項目總投資額約為540萬美元,將集中於開發、改善和商業化三種面向消費者的蛋白產品。Acenzia將貢獻約60萬美元,而Protein Industries Canada和其他兩家合作夥伴公司將分別投資230萬美元和250萬美元。這個項目將分三個階段進行,旨在提供與乳清分離蛋白質相當的質量、感官體驗和肌肉健康益處的植物蛋白替代品。產品面向不同的消費者群體,包括...展開全部
2024年6月5日,Novo Integrated Sciences, Inc.宣佈其子公司Acenzia Inc.被Protein Industries Canada選為參與項目的合夥人,旨在將具有增強營養價值的新蛋白產品引入全球市場。該項目總投資額約為540萬美元,將集中於開發、改善和商業化三種面向消費者的蛋白產品。Acenzia將貢獻約60萬美元,而Protein Industries Canada和其他兩家合作夥伴公司將分別投資230萬美元和250萬美元。這個項目將分三個階段進行,旨在提供與乳清分離蛋白質相當的質量、感官體驗和肌肉健康益處的植物蛋白替代品。產品面向不同的消費者群體,包括醫療營養、活力生活和高性能體育。Acenzia的參與將利用其在合同生產、產品配方、研發和可持續包裝方面的專業知識,創建具有生態友好、基於證據的植物蛋白產品。母公司Novo Integrated Sciences, Inc.以其跨學科的醫療生態系統和產品創新聞名,注重健康和福祉的整體方法。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息